|
Real-time Estimate
Cboe BZX
12:37:33 13/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 3.910 USD | +3.71% |
|
-1.82% | -26.51% |
| 30/07 | Alvotech Announces Successful Closure Of U.S Food and Drug Administration Inspection Of Manufacturing Facility | CI |
| 29/07 | Alvotech Shares Rise After Wrapping FDA Facility Inspection | DJ |
| Market Cap | 135.63Cr 117.51Cr 110.1Cr 100.42Cr 188.79Cr 13TCr 191.69Cr 1.29TCr 506.17Cr 6.48TCr 509.22Cr 498.16Cr 22TCr | P/E 2026 * |
14.3x | P/E 2027 * | 8.29x |
|---|---|---|---|---|---|
| Enterprise Value | 243.97Cr 211.37Cr 198.05Cr 180.64Cr 339.61Cr 23TCr 344.83Cr 2.33TCr 910.52Cr 12TCr 916.01Cr 896.1Cr 39TCr | EV / Sales 2026 * |
3.72x | EV / Sales 2027 * | 3.06x |
| Free-Float |
45.12% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Alvotech
| 1 day | +3.05% | ||
| 1 week | -1.82% | ||
| Current month | -8.50% | ||
| 1 month | +14.94% | ||
| 3 months | +5.01% | ||
| 6 months | -22.27% | ||
| Current year | -26.51% |
| 1 week | 3.68 |  | 3.88 |
| 1 month | 3.04 | | 4.12 |
| Current year | 2.94 | | 5.58 |
| 1 year | 2.94 | | 9.25 |
| 3 years | 2.94 | | 18 |
| 5 years | 2.94 | | 18 |
| 10 years | 2.94 | | 18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lisa Graver
CEO | Chief Executive Officer | 55 | 01/03/2026 |
Linda Jonsdottir
DFI | Director of Finance/CFO | 48 | 10/07/2025 |
Giedrius Zunda
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Vilhelm Wessman
CHM | Chairman | 56 | 01/01/2019 |
Richard Davies
BRD | Director/Board Member | 64 | 01/01/2019 |
Tomas Ekman
BRD | Director/Board Member | 58 | 01/01/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 26/02/26 | Buy | Founder | 27,01,617 | 0.9038% | ||
| 26/02/26 | Aztiq Pharma Partners SARL
| Buy | Company | 27,01,617 | 0.9038% | |
| 15/02/26 | Sell | Founder | 27,01,617 | 0.9038% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.71% | -1.82% | -55.75% | -57.64% | 135.63Cr | |
| -1.60% | +0.86% | +3.70% | +14.57% | 4.95TCr | |
| -0.38% | +3.51% | +479.21% | +580.77% | 4.41TCr | |
| -0.34% | +9.19% | +24.13% | +75.19% | 4.08TCr | |
| -0.37% | +3.03% | +30.82% | +10.49% | 4.01TCr | |
| -4.04% | +8.72% | +22.60% | +48.00% | 3.42TCr | |
| -1.20% | +2.27% | +30.88% | +126.31% | 1.69TCr | |
| +0.31% | +4.42% | - | - | 1.68TCr | |
| -0.43% | -0.11% | +4.22% | +20.71% | 1.4TCr | |
| +1.64% | +10.24% | +88.16% | +32.51% | 1.35TCr | |
| Average | -0.36% | +6.09% | +69.77% | +94.54% | 2.71TCr | |
| Weighted average by Cap. | -0.97% | +6.46% | +102.11% | +134.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 66Cr 57Cr 53Cr 49Cr 91Cr 6.26TCr 93Cr 626.61Cr 244.94Cr 3.13TCr 246.41Cr 241.06Cr 10TCr | 79Cr 69Cr 64Cr 59Cr 110.32Cr 7.56TCr 112.01Cr 756.65Cr 295.77Cr 3.78TCr 297.55Cr 291.09Cr 13TCr |
| Net income | 9.18Cr 7.95Cr 7.45Cr 6.8Cr 13Cr 875.54Cr 13Cr 88Cr 34Cr 438.39Cr 34Cr 34Cr 1.46TCr | 15Cr 13Cr 12Cr 11Cr 21Cr 1.44TCr 21Cr 144.52Cr 56Cr 722.91Cr 57Cr 56Cr 2.41TCr |
| Net Debt | 108.34Cr 94Cr 88Cr 80Cr 150.81Cr 10TCr 153.13Cr 1.03TCr 404.34Cr 5.17TCr 406.78Cr 397.94Cr 17TCr | 106.53Cr 92Cr 86Cr 79Cr 148.29Cr 10TCr 150.57Cr 1.02TCr 397.58Cr 5.09TCr 399.97Cr 391.28Cr 17TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/26/10 | $3.770 | -1.05% | 10,22,803 |
| 11/26/11 | $3.800 | +0.80% | 7,72,808 |
| 10/26/10 | $3.770 | -1.05% | 10,22,803 |
| 07/26/07 | $3.810 | +0.26% | 3,42,030 |
| 06/26/06 | $3.800 | +1.06% | 5,03,348 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALVO Stock
Select your edition
All financial news and data tailored to specific country editions
